The Patent Finder

Flamel Ireland Limited

59 patents currently held · Updated Nov 21, 2026
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Jul 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 26, 2027
    The maintenance fee for Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics (US 11,766,418) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
  • 1 fee due Apr 10, 2027
    The maintenance fee for Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics (US 11,779,557) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 1 fee due May 28, 2027
    The maintenance fee for Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics (US 11,826,335) comes due May 28, 2027. Unpaid by Nov 29, 2027, it lapses early.
  • 1 fee due Jun 12, 2027
    The maintenance fee for Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics (US 11,839,597) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
  • 1 fee due Jul 12, 2027
    The maintenance fee for N-Phosphonomethylglycine Guanidine Derivative Salts (US 9,233,993) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics (US 11,896,572) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
  • 1 fee due Nov 14, 2027
    The maintenance fee for Compound embodiments for hydrogen sulfide production and methods of making and using the same (US 11,981,626) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US RE47,084Oral Medicinal Product with Modified Release of at Least One Active Principle in Multimicrocapsular Form
In force
 · Low confidence
In forceLow confidence
US 8,507,003Compressed tablets comprising microcapsules with modified release
In force
 · High confidence
In forceHigh confidence
US 10,092,511Controlled-Release Floating Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 9,775,355Guanidine Derivative Compounds
In force
 · High confidence
In forceHigh confidence
US 9,561,179Controlled-Release Floating Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 11,602,512Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
In force
 · Low confidence
In forceLow confidence
US 11,826,335Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
In force
 · High confidence
In forceHigh confidence
US 11,839,597Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
In force
 · High confidence
In forceHigh confidence
US 12,115,145Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
In force
 · Medium confidence
In forceMedium confidence
US 12,144,793Modified Release Gamma-Hydroxybutyrate Formulations Having Improved Pharmacokinetics
In force
 · Medium confidence
In forceMedium confidence
10 of 59 patents shown.
Pro members see all 59.
Pro members: see all 59 patents
Also on record, not counted in the 59: 8 patents in force now held by others · 9 lapsed for an unpaid fee · 8 ended at full term · 2 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 16 abandoned · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited